Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Attendees of the American College of Cardiology conference bemoan the cancellation of Boston Scientific’s Watchman trial presentation, but conference organizers stand behind their decision to scrub the report after the device maker breached an embargo on the study results.
The software flaw that allowed a duo of cybersecurity researchers to bring down a Philips XPER hospital management system with 6 lines of code is still a problem in current XPER machines, Philips tells MassDevice.com.
Veteran cardiologist and patient safety advocate Dr. Robert Hauser tells MassDevice.comabout his new vision for healthcare surveillance, his long struggle to spur change at the FDA and what FDA regulators can learn from aviation regulation.